Royal Bank of Canada
SRNE

Royal Bank of Canada’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-71,411
Closed -$64K 7214
2022
Q4
$64K Buy
71,411
+60,677
+565% +$54.4K ﹤0.01% 5287
2022
Q3
$16K Buy
10,734
+757
+8% +$1.13K ﹤0.01% 5754
2022
Q2
$20K Sell
9,977
-28,254
-74% -$56.6K ﹤0.01% 5659
2022
Q1
$88K Sell
38,231
-165,084
-81% -$380K ﹤0.01% 5270
2021
Q4
$946K Buy
203,315
+152,206
+298% +$708K ﹤0.01% 3400
2021
Q3
$390K Buy
51,109
+12,767
+33% +$97.4K ﹤0.01% 4072
2021
Q2
$372K Buy
38,342
+615
+2% +$5.97K ﹤0.01% 4083
2021
Q1
$311K Buy
37,727
+7,906
+27% +$65.2K ﹤0.01% 4119
2020
Q4
$203K Sell
29,821
-8,603
-22% -$58.6K ﹤0.01% 4324
2020
Q3
$428K Buy
38,424
+22,623
+143% +$252K ﹤0.01% 3551
2020
Q2
$99K Sell
15,801
-13,045
-45% -$81.7K ﹤0.01% 4391
2020
Q1
$54K Buy
28,846
+27,721
+2,464% +$51.9K ﹤0.01% 4625
2019
Q4
$4K Buy
1,125
+1,000
+800% +$3.56K ﹤0.01% 5834
2019
Q3
$0 Hold
125
﹤0.01% 6275
2019
Q2
$0 Buy
+125
New ﹤0.01% 6104
2018
Q4
Sell
-8,345
Closed -$37K 6267
2018
Q3
$37K Buy
8,345
+3,998
+92% +$17.7K ﹤0.01% 4781
2018
Q2
$31K Buy
4,347
+3,547
+443% +$25.3K ﹤0.01% 4781
2018
Q1
$4K Buy
800
+653
+444% +$3.27K ﹤0.01% 5397
2017
Q4
$1K Buy
147
+114
+345% +$776 ﹤0.01% 5683
2017
Q3
$0 Sell
33
-4,467
-99% ﹤0.01% 6201
2017
Q2
$9K Buy
4,500
+3,562
+380% +$7.12K ﹤0.01% 5111
2017
Q1
$4K Buy
938
+116
+14% +$495 ﹤0.01% 5615
2016
Q4
$4K Buy
822
+741
+915% +$3.61K ﹤0.01% 5607
2016
Q3
$1K Buy
+81
New +$1K ﹤0.01% 5555
2016
Q1
Sell
-73
Closed -$1K 5842
2015
Q4
$1K Sell
73
-1,223
-94% -$16.8K ﹤0.01% 5740
2015
Q3
$11K Sell
1,296
-242
-16% -$2.05K ﹤0.01% 5263
2015
Q2
$27K Buy
+1,538
New +$27K ﹤0.01% 5061